Page last updated: 2024-08-16

ribavirin and Asthenia

ribavirin has been researched along with Asthenia in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (57.14)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armienta-Sarabia, R; Cordero-Pérez, P; Hernández-Gómez, ME; Malé-Velázquez, R; Marín-López, E; Muñoz-Espinosa, LE; Núñez-Camarena, Jde J; Olivera-Martínez, MA; Sánchez-Avila, JF; Torres-González, L	1
Ahlers, S; Bakalos, G; Coppola, C; Derbala, M; Ferenci, P; Foster, GR; Hassanein, T; Orlandini, A; Reddy, KR; Shiffman, ML; Tallarico, L	1
Chen, H; Huang, P; Li, J; Liu, M; Wang, J; Yao, Y; Yu, R; Yue, M; Zang, F; Zhang, Y	1
Bailly, F; Chevallier, M; Chevallier, P; Rocca, P; Trépo, C; Zoulim, F	1
Alaric, L; Bureau, C; Péron, JM; Pey, F; Valmary, S; Vinel, JP; Zabraniechki, L	1
Brosig, B; Gieler, U; Holthausen-Markou, S; Schreiber, M; Wölfelschneider, M	1
Ray, SC; Sulkowski, MS; Thomas, DL	1

Trials

1 trial(s) available for ribavirin and Asthenia

Article	Year
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort. PloS one, 2016, Volume: 11, Issue:3 Topics: Adult; Aged; Anemia; Antiviral Agents; Asthenia; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Interferon-alpha; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; RNA, Viral; Withholding Treatment	2016

Article

Year

Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.

PloS one, 2016, Volume: 11, Issue:3

Topics: Adult; Aged; Anemia; Antiviral Agents; Asthenia; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Interferon-alpha; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; RNA, Viral; Withholding Treatment

2016

Other Studies

6 other study(ies) available for ribavirin and Asthenia

Article	Year
Re-treatment with highly purified nIFNα in Mexican nonresponder patients with chronic genotype 1 hepatitis C. Archives of medical research, 2013, Volume: 44, Issue:6 Topics: Antiviral Agents; Asthenia; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Obesity; Pilot Projects; Prospective Studies; Recombinant Proteins; Retreatment; Ribavirin; Viral Load	2013
Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis. Canadian journal of gastroenterology & hepatology, 2017, Volume: 2017 Topics: Amides; Antiviral Agents; Asthenia; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Nausea; Quinoxalines; Randomized Controlled Trials as Topic; Ribavirin; RNA, Viral; Sulfonamides; Sustained Virologic Response; Viral Load	2017
[Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients]. Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:3 Pt 1 Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Asthenia; Diarrhea; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Jaundice; Male; Middle Aged; Needlestick Injuries; Pain; Punctures; Recombinant Proteins; Retrospective Studies; Ribavirin; Serotyping; Sexual Behavior; Substance Abuse, Intravenous; Tattooing; Time Factors; Treatment Outcome	2003
Treatment of chronic hepatitis C in a patient with systemic lupus erythematosus. Gastroenterologie clinique et biologique, 2004, Volume: 28, Issue:12 Topics: Aged; Anemia; Antiviral Agents; Asthenia; Drug Therapy, Combination; Female; Headache; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Lupus Erythematosus, Systemic; Ribavirin	2004
[Psychological side effects during interferon-alpha therapy -- a case study]. Psychiatrische Praxis, 2006, Volume: 33, Issue:2 Topics: Adult; Antiviral Agents; Asthenia; Combined Modality Therapy; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Psychoanalytic Therapy; Psychophysiologic Disorders; Recombinant Proteins; Retreatment; Ribavirin; Sick Role; Substance Withdrawal Syndrome	2006
Needlestick transmission of hepatitis C. JAMA, 2002, May-08, Volume: 287, Issue:18 Topics: Accidents, Occupational; Acute Disease; Adult; Anti-HIV Agents; Antiviral Agents; Asthenia; Exanthema; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Interferon alpha-2; Interferon-alpha; Internship and Residency; Lamivudine; Needlestick Injuries; Nelfinavir; Occupational Exposure; Physicians; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viremia; Zidovudine	2002